Andreas Kaufmann

Andreas Kaufmann is the head of research at the Department of Gynaecology of the Charité-Universitätsmedizin Berlin, Germany. Dr. Kaufmann is responsible for the development and organisation of clinical studies with companies and academic translational basic research. His research laboratory focuses on characterization of tumour-specific immune responses and development and evaluation of tumour vaccination strategies. Cervical cancer and Human Papillomavirus are the primary targets of his research. He studied Biology at the University of Heidelberg and thereafter, pursued his PhD at the German Cancer Centre working on tumour metastasis and EGF receptor signalling. In 1994, he proceeded to Loyola University at Chicago to join the laboratory of Lutz Gissmann and started working on Human Papillomavirus immunology. Returning to Germany in 1997, he became interested in clinical testing of experimental vaccines and joined the group of Achim Schneider in Jena. Dr. Kaufmann’s current interests are T cell immunology of HPV vaccination of both prophylactic and therapeutic approaches. His laboratory has developed sensitive T cell assays, which are currently being validated for their use in clinical studies. His laboratory is also involved in: HPV testing for diagnostic purposes on patients and subjects recruited into studies, and the investigation of HPV gene expression in correlates of disease progression to identify potential progression markers. In addition, his group investigates the biologic and immunologic features of cancer stem cells of HPV-related cervical and head-and-neck cancer. Dr. Kaufmann’s emphasis is on translational research making innovative methods and therapies available to patients.

 

Responsive Free Joomla template by L.THEMESEO